Lixing Zhang

3.3k total citations
89 papers, 2.3k citations indexed

About

Lixing Zhang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lixing Zhang has authored 89 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Lixing Zhang's work include Cancer Cells and Metastasis (18 papers), Immunotherapy and Immune Responses (8 papers) and Immune cells in cancer (6 papers). Lixing Zhang is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Immunotherapy and Immune Responses (8 papers) and Immune cells in cancer (6 papers). Lixing Zhang collaborates with scholars based in China, United Kingdom and United States. Lixing Zhang's co-authors include Suling Liu, Jinjun Li, Chao Ge, Fangyu Zhao, Xiaojing Ma, Ming Yao, G. F. Kirkbright, Yao Chen, Lei Zhou and Taoyang Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lixing Zhang

83 papers receiving 2.2k citations

Peers

Lixing Zhang

ONCOL

IMMUN

EOMM

Yanping Gao China

Fangyuan Wang China

Tianhui Hu China

Jingmei Liu China

Qiang Gu China

Wei Shi China

Yingying Wei China

Xianghong Li China

Wenying Yu China

Yanping Gao China

Lixing Zhang

1.2k ×1.1

208 ×0.3

ONCOL

158 ×0.4

IMMUN

568 ×1.4

125 ×0.7

EOMM

Citations per year, relative to Lixing Zhang Lixing Zhang (= 1×) peers Yanping Gao

Countries citing papers authored by Lixing Zhang

Since Specialization

Citations

This map shows the geographic impact of Lixing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixing Zhang more than expected).

Fields of papers citing papers by Lixing Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixing Zhang. The network helps show where Lixing Zhang may publish in the future.

Co-authorship network of co-authors of Lixing Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lixing Zhang. A scholar is included among the top collaborators of Lixing Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixing Zhang. Lixing Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Lixing, Gang Guo, Zhenbo Tong, Ya Zhang, & Aibing Yu. (2025). Numerical study on the effect of individual variations on inhaled drug particle deposition distribution in grouped realistic inhaler-airway models. Powder Technology. 457. 120881–120881.

Wang, Sheng, et al.. (2025). Identification and optimization of ecological corridors in the middle reaches of the Yellow River Basin. Journal of Cleaner Production. 512. 145676–145676. 1 indexed citations

Zhang, Lixing, Zhenbo Tong, Ya Zhang, & Aibing Yu. (2024). Numerical study on the deposition distribution and mechanism of inhaled drug particles in various regions of the realistic inhaler-airway model. Powder Technology. 449. 120402–120402. 6 indexed citations

Zhang, Lixing, Juchuanli Tu, Siqin Li, et al.. (2024). IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer Research. 84(14). 2282–2296. 26 indexed citations

Sheng, Dandan, W. F. Mader, Rui Zhang, et al.. (2022). Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. Journal for ImmunoTherapy of Cancer. 10(5). e003793–e003793. 51 indexed citations

Xu, Jiahui, Xiaoli Yang, Qiaodan Deng, et al.. (2021). TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. Nature Communications. 12(1). 4413–4413. 50 indexed citations

Su, Gang, Lihua Liu, Lixing Zhang, et al.. (2021). Fabrication of magnetic Fe3O4@SiO2@Bi2O2CO3/rGO composite for enhancing its photocatalytic performance for organic dyes and recyclability. Environmental Science and Pollution Research. 28(36). 50286–50301. 20 indexed citations

Ban, Yi, Junhua Mai, Xin Li, et al.. (2017). Targeting Autocrine CCL5–CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity. Cancer Research. 77(11). 2857–2868. 122 indexed citations

Liao, Liqiu, Mei Song, Xin Li, et al.. (2017). E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. Cancer Research. 77(8). 2090–2101. 86 indexed citations

10.

Zhang, Lixing, Chao Ge, Fangyu Zhao, et al.. (2016). NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling. Cancer Research. 76(23). 7059–7071. 36 indexed citations

11.

Hou, Helei, Hefen Sun, Ping Lü, et al.. (2013). Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 12(12). 2874–2884. 56 indexed citations

12.

Zhang, Lixing, Hefen Sun, Fangyu Zhao, et al.. (2012). BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma. Cancer Research. 72(16). 4276–4285. 82 indexed citations

13.

Xu, Hongtao, Jun Ye, Lixing Zhang, et al.. (2011). Changes in the Proportions of CD4⁺T Cell Subsets Defined by CD127 and CD25 Expression during HBV Infection. Immunological Investigations. 41(3). 290–303. 1 indexed citations

14.

Zhang, Lixing. (2008). Structure,Effect and Regulation of the Ubiquitin-Proteasome System. Bulletin of Science and Technology. 1 indexed citations

15.

Zhang, Lixing. (2007). Optimization of Fermentation Technology for Chitinase Production by Aeromonas hydrophila sp.. Bulletin of Science and Technology. 1 indexed citations

16.

Zhang, Lixing. (2004). Radioactive noble gases monitoring for the verification of the Comprehensive Nuclear Test-Ban Treaty. Nuclear Techniques.

17.

Xu, Qun, Zhenglai Wu, Shuigao Jin, & Lixing Zhang. (2002). Tuberculosis control priorities defined by using cost-effectiveness and burden of disease.. PubMed. 15(2). 172–6. 2 indexed citations

18.

Xu, Qun, et al.. (2002). Methodology for the assessment of burden of smear-positive pulmonary TB and its infectivity.. PubMed. 15(1). 8–15. 1 indexed citations

19.

Zhang, Lixing, Dehua Tu, Guangxue He, et al.. (2000). Risk of Tuberculosis Infection and Tuberculous Meningitis after Discontinuation of Bacillus Calmette–Guerin in Beijing. American Journal of Respiratory and Critical Care Medicine. 162(4). 1314–1317. 17 indexed citations

20.

Yan, Lu, et al.. (1992). Investigation of natural radioactivity level of the waters in Jilin Province. 12(5). 389–392.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact